Sequential antimicrobial therapy: treatment of severe lower respiratory tract infections in children

被引:23
作者
Al-Eidan, FA
McElnay, JC
Scott, MG
Kearney, MP
Troughton, KEU
Jenkins, J
机构
[1] Queens Univ Belfast, Pharm Pract Res Grp, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland
[2] Antrim Area Hosp, Antrim Hosp Acad Pharm Practice Unit, Antrim BT41 2RL, North Ireland
[3] United Hosp Grp Trust, Dept Microbiol, Antrim BT41 2RL, North Ireland
[4] United Hosp Grp Trust, Dept Paediat, Antrim BT41 2RL, North Ireland
关键词
D O I
10.1093/jac/44.5.709
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Although there have been a number of studies in adults, to date there has been little research into sequential antimicrobial therapy (SAT) in paediatric populations. The present study evaluates the impact of a SAT protocol for the treatment of severe lower respiratory tract infection in paediatric patients. The study involved 89 paediatric patients (44 control and 45 SAT). The SAT patients had a shorter length of hospital stay (4.0 versus 8.3 days), shorter duration of inpatient antimicrobial therapy (4.0 versus 7.9 days) with the period of iv therapy being reduced from a mean of 5.6 to 1.7 days. The total healthcare costs were reduced by 52%. The resolution of severe lower respiratory tract infection with a short course of iv antimicrobials, followed by conversion to oral therapy yielded clinical outcomes comparable to those achieved using longer term iv therapy. SAT proved to be an important cost-minimizing tool for realizing substantial healthcare costs savings.
引用
收藏
页码:709 / 715
页数:7
相关论文
共 33 条
  • [1] Allen Barbara, 1992, Australian Journal of Hospital Pharmacy, V22, P434
  • [2] Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: A pharmacoeconomic analysis
    AmodioGroton, M
    Madu, A
    Madu, CN
    Briceland, LL
    Seligman, M
    McMaster, P
    Miller, MH
    [J]. ANNALS OF PHARMACOTHERAPY, 1996, 30 (06) : 596 - 602
  • [3] Balfour J A, 1993, Pharmacoeconomics, V3, P398, DOI 10.2165/00019053-199303050-00007
  • [4] CEFUROXIME AND CEFUROXIME AXETIL VERSUS AMOXICILLIN PLUS CLAVULANIC ACID IN THE TREATMENT OF LOWER RESPIRATORY-TRACT INFECTIONS
    BRAMBILLA, C
    KASTANAKIS, S
    KNIGHT, S
    CUNNINGHAM, K
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (02) : 118 - 124
  • [5] Intravenous-to-oral antibiotic switch therapy - A cost-effective approach
    Cunha, BA
    [J]. POSTGRADUATE MEDICINE, 1997, 101 (04) : 111 - &
  • [6] PARENTERAL-ORAL SWITCH IN THE MANAGEMENT OF PEDIATRIC PNEUMONIA
    DAGAN, R
    SYROGIANNOPOULOS, G
    ASHKENAZI, S
    ENGELHARD, D
    EINHORN, M
    GATZOLAKARAVELLI, M
    SHALIT, I
    AMIR, J
    [J]. DRUGS, 1994, 47 : 43 - 51
  • [7] Gardner MJ, 1989, STAT CONFIDENCE CONF
  • [8] PARENTERAL FOLLOWED BY ORAL OFLOXACIN FOR NOSOCOMIAL PNEUMONIA AND COMMUNITY-ACQUIRED PNEUMONIA REQUIRING HOSPITALIZATION
    GENTRY, LO
    RODRIGUEZGOMEZ, G
    KOHLER, RB
    KHAN, FA
    RYTEL, MW
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1992, 145 (01): : 31 - 35
  • [9] INVITRO ACTIVITY OF ORALLY-ADMINISTERED ANTIMICROBIAL AGENTS AGAINST HAEMOPHILUS-INFLUENZAE RECOVERED FROM CHILDREN MONITORED LONGITUDINALLY IN A GROUP DAY-CARE-CENTER
    GEORGE, MJ
    KITCH, B
    HENDERSON, FW
    GILLIGAN, PH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) : 1960 - 1964
  • [10] Guay D R, 1993, Pharmacoeconomics, V3, P341, DOI 10.2165/00019053-199303050-00001